BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2906118)

  • 1. CHOP regimen versus intermittent chlorambucil-prednisone in stage B chronic lymphocytic leukemia. Short term results from a randomized clinical trial. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):449-52. PubMed ID: 2906118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of fludarabine, cyclophosphamide/doxorubicin/prednisone, and cyclophosphamide/doxorubicin/vincristine/prednisone in advanced forms of chronic lymphocytic leukemia: preliminary results of a controlled clinical trial. The French Cooperative Group on Chronic Lymphocytic Leukemia.
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):21-3. PubMed ID: 8235691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy of chronic lymphocytic leukemia patients. Results from the French cooperative trials. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):443-8. PubMed ID: 3065741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High dose chlorambucil versus Binet's modified cyclophosphamide, doxorubicin, vincristine, and prednisone regimen in the treatment of patients with advanced B-cell chronic lymphocytic leukemia. Results of an international multicenter randomized trial. International Society for Chemo-Immunotherapy, Vienna.
    Jaksic B; Brugiatelli M; Krc I; Losonczi H; Holowiecki J; Planinc-Peraica A; Kusec R; Morabito F; Iacopino P; Lutz D
    Cancer; 1997 Jun; 79(11):2107-14. PubMed ID: 9179056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The experience of the French Cooperative Group in the treatment of CLL.
    Travade P
    Nouv Rev Fr Hematol (1978); 1990; 32(5):313-7. PubMed ID: 2099402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy.
    Liso V; Molica S; Capalbo S; Pogliani E; Battista C; Broccia G; Montillo M; Cuneo A; Leoni P; Specchia G; Castoldi G
    Haematologica; 2001 Nov; 86(11):1165-71. PubMed ID: 11694402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CHOP versus prednisolone + chlorambucil in chronic lymphocytic leukemia (CLL): preliminary results of a randomized multicenter study.
    Hansen MM; Andersen E; Christensen BE; Christiansen I; Geisler C; Kristensen D; Jensen KB; Junker P
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):433-6. PubMed ID: 3065739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Dighiero G; Maloum K; Desablens B; Cazin B; Navarro M; Leblay R; Leporrier M; Jaubert J; Lepeu G; Dreyfus B; Binet JL; Travade P
    N Engl J Med; 1998 May; 338(21):1506-14. PubMed ID: 9593789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial comparing chlorambucil plus prednisone vs cyclophosphamide, melphalan, and prednisone in the treatment of chronic lymphocytic leukemia stages B and C.
    Montserrat E; Alcalá A; Alonso C; Besalduch J; Moraleda JM; García-Conde J; Gutierrez M; Gomis F; Garijo J; Guzmán MC
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):429-32. PubMed ID: 3065738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. When and how to treat elderly patients with chronic lymphocytic leukemia (C.L.L.)? The French Cooperative Group on C.L.L.
    Binet JL
    Hematol Oncol; 1993; 11 Suppl 1():38. PubMed ID: 8486339
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of "CHOP" regimen in advanced untreated chronic lymphocytic leukaemia. French Cooperative Group on Chronic Lymphocytic Leukaemia.
    Lancet; 1986 Jun; 1(8494):1346-9. PubMed ID: 2872470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of subsequent therapies in patients with chronic lymphocytic leukemia previously treated with prednisone and either cladribine or chlorambucil.
    Robak T; Blonski JZ; Kasznicki M; Góra-Tybor J; Dmoszyñska A; Skotñicki A
    Haematologica; 2005 Jul; 90(7):994-6. PubMed ID: 15996945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of cladribine plus prednisone with chlorambucil plus prednisone in patients with chronic lymphocytic leukemia. Final report of the Polish Adult Leukemia Group (PALG CLL1).
    Robak T; Błoński JZ; Kasznicki M; Góra-Tybor J; Dmoszyńska A; Wojtaszko M; Skotnicki AB; Nowak W; Hellmann A; Lewandowski K; Zdziarska B; Konopka L; Ceglarek B; Dwilewicz-Trojaczek J; Boguradzki P; Kuliczkowski K; Sułek K; Warzocha K
    Med Sci Monit; 2005 Oct; 11(10):PI71-9. PubMed ID: 16192912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose continuous chlorambucil vs intermittent chlorambucil plus prednisone for treatment of B-CLL--IGCI CLL-01 trial.
    Jaksić B; Brugiatelli M
    Nouv Rev Fr Hematol (1978); 1988; 30(5-6):437-42. PubMed ID: 3065740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of chlorambucil and prednisone versus cyclophosphamide, vincristine, and prednisone as initial treatment for chronic lymphocytic leukemia: long-term follow-up of an Eastern Cooperative Oncology Group randomized clinical trial.
    Raphael B; Andersen JW; Silber R; Oken M; Moore D; Bennett J; Bonner H; Hahn R; Knospe WH; Mazza J
    J Clin Oncol; 1991 May; 9(5):770-6. PubMed ID: 2016618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparing CHOP, CHOP+HD-MTX,and BFM-90 regimens in the survival rate of children and adolescents with B cell non-Hodgkin's lymphoma].
    Sun XF; Su YS; Liu DG; Jiang WQ; He YJ; Lin TY; Huang HQ; Zhang L; Xia ZJ; Li YH; Zhou ZM; Chen XQ; Xia Y; Zhen ZJ; Guan ZZ
    Ai Zheng; 2004 Aug; 23(8):933-8. PubMed ID: 15301718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of the pilot treatment of 9 patients with chronic lymphocytic leukemia or CLL lymphoplasmacytoid lymphoma by the CHOP protocol].
    Roliński J; Rupniewska ZM; Kowalewski J; Kowal M; Wach M
    Acta Haematol Pol; 1990; 21(2):185-91. PubMed ID: 2131718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia.
    Leuk Lymphoma; 1994 May; 13(5-6):449-56. PubMed ID: 8069190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chronic lymphocytic leukemia in Subsaharian Africa: clinical outcome experience of Côte d'Ivoire].
    Koffi KG; Nanho DC; Tolo A; N'Dathz E; Kouakou B; Meite N; Ayemou R; Sanogo I
    Bull Cancer; 2009 Sep; 96(9):901-6. PubMed ID: 19696007
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.